Position in OCUL
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,981,499
-$4,295,973 QoQ
Shares Held
201,782
-72.8% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#81
of 257 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Derivatives in OCUL
reported options exposure · as of Jun 30, 2026CallValue
$236,662
CallShares
24,100
PutValue
$105,074
PutShares
10,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,313,978 across 124 Biotechnology names. OCUL ranks #42 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in OCUL
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $105,074 | 10,700 | Put | Sole | 2026-08-03 | |
| 2026-06-30 | $1,981,499 | 201,782 | Shares | Sole | 2026-08-03 | |
| 2026-06-30 | $236,662 | 24,100 | Call | Sole | 2026-08-03 | |
| 2026-03-31 | $6,277,472 | 741,142 | Shares | Sole | 2026-05-13 | |
| 2026-03-31 | $116,039 | 13,700 | Put | Sole | 2026-05-13 | |
| 2025-12-31 | $2,798,379 | 230,509 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $1,214 | 100 | Put | Sole | 2026-02-13 | |
| 2025-09-30 | $711,231 | 60,841 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $25,718 | 2,200 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $170,674 | 14,600 | Put | Sole | 2025-11-14 | |
| 2024-12-31 | $90,079 | 10,548 | Shares | Sole | 2025-02-13 | |
| 2024-03-31 | $746,727 | 82,058 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $225,311 | 43,665 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $99,133 | 18,811 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $76,635 | 15,482 | Shares | Sole | 2022-05-27 | |
| 2021-12-31 | $498,041 | 71,455 | Shares | Sole | 2022-05-27 | |
| 2020-06-30 | $289,051 | 34,700 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $54,450 | 11,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||